Lisa Dean v. Wyeth, Inc., et al.
On July 20, 2007, a jury in the US District Court in St. Louis decided in favor of Wyeth in a diet-drug case brought by Lisa Dean, a South Carolina woman. Lisa Dean claimed that one of her heart valves had been damaged by an appetite-suppressing medication sold by Wyeth. Our trial team was led by partners Sean Laane and Steven Reade in the Washington, DC, office. The jury returned the verdict inside of an hour after a one-week trial and was the latest in a series of favorable verdicts - either for the defense or awarding low damages - that the firm has achieved in the diet drug litigation in recent years. In March 2006, in two separate trials in the Philadelphia Court of Common Pleas, our trial lawyers obtained defense verdicts in the cases of four plaintiffs who also alleged heart valve damage.
Our attorneys serve as national coordinating counsel and trial counsel for Wyeth in its diet drug litigation. The cases involve a wide range of issues, including compliance with FDA new-drug and adverse-reporting regulations, the development and evaluation of epidemiological and clinical data, and novel class action issues in both the litigation and settlement contexts. The firm is one of the nation's leading law firms in defending mass tort cases, acting as national counsel and trial counsel in cases asserting both personal injury and damage claims. More than 80 of the firm's attorneys are actively engaged in product liability matters.